SPP1 and breast carcinoma: Unfortunately, the extensive posttranslational modifications of the molecule together with its physiologic role in cellular immunity and its secretion into the breast milk for calcium binding have limited the biomarker potential of OPN in cancer, and specifically in breast cancer.